FindTrial
Sign In

Effect of stellate ganglion block on patients with awake craniotomy

Effect of stellate ganglion block on patients with awake craniotomy,a randomised trial.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR1900002323
Enrollment
Unknown
Registered
2019-05-08
Start date
2019-05-11
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

awake craniotomy

Interventions

SGB group:ultrasound guided stellate ganglion block with 5ml of 0.5% ropivacaine
Control group:SBG with saline

Sponsors

Guangdong Sanjiu Brain Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients of American Society of Anesthesiologists (ASA) physical status I to III patients, aged 18 to 80 years, awake craniotomy, provide the informed consent, will be enrolled in this study.

Exclusion criteria

Exclusion criteria: Pregnant or lactating women; Patients suffering from chronic diseases, liver, kidney, cardiovascular disease;Psychosis or severe nerve recession; Patients that fail to block stellate ganglion; Coagulopathy, infection at the needle insertion site, allergy to local anesthetics, body mass index more than 35kg/m2.

Design outcomes

Primary

MeasureTime frame
State-Trait Anxiety Inventory(STAI), numerical rating scale (NRS)and VAS;Determination of the Oxidative Production and Antioxidative Enzymes;—

Secondary

MeasureTime frame
Blood pressure, respiratory rate,heart rate and BIS;Blood loss volume and operative time;Demographic information;—

Countries

China

Contacts

Public ContactWei Jianqi

The First Affiliated Hospital of Guangzhou University of Chinese Medicine

weijianqi@aliyun.com+86 13926007560

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026